Evaxion introduces EVX-04, a novel vaccine candidate targeting multiple non-conventional ERV tumor antigens, developed withour AI-Immunology™ platformEVX-04 is a therapeutic cancer vaccine candidate ...
When Sean Fletcher walked into Sam Biswas' Medical and Molecular Sciences (MMSC) lab at the University of Delaware College of Health Sciences during the summer of his first year, he had no research or ...
This study presents a valuable finding on mutations in ZNF217, ZNF703, and ZNF750 through 23 breast cancer samples alongside matched normal tissues in Kenyan breast cancer patients. The evidence ...
New UC San Diego research shows that pharmacists can play a crucial role in helping people with cancer and diabetes better ...
Researchers have developed an AI-assisted technology that can identify and tag chromosomal abnormalities in cells.
A $483,620 federal grant will transform how Spelman College prepares the next generation of biomedical scientists. Mentewab Ayalew, Ph.D., a professor of biology, has secured three years of funding ...
Rising Cancer Incidence Fuels Demand for Smart Nanomedicine Solutions in Oncology CareThe Smart Cancer Nanomedicine Market ...
Research in the field of ubiquitination has unveiled it as a fundamental post-translational modification mechanism that ...
Advancements in bioinformatics and systems biology have revolutionized our understanding of complex diseases, paving the way ...
Emma's brain tumour has stopped growing since she gained access to a type of immunotherapy identified by molecular testing.
Oncology-focused biotech company Guardant Health is partnering with AI drug development company Zephyr AI to combine AI and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results